CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer

Condition:   Advanced Esophageal Cancer
Interventions:   Biological: Anti-MUC1 CAR-T cells;   Biological: PD-1 knockout Engineered T cells;   Combination Product: CAR-T combined with PD-1 Knockout T cells
Sponsors:   The First Affiliated Hospital of Guangdong Pharmaceutical University;   Guangzhou Anjie Biomedical Technology Co;LTD
Recruiting

https://ift.tt/2RUNxxD